Prognostic importance of hyperplasia and atypia in endometriosis

被引:78
作者
Seidman, JD [1 ]
机构
[1] ARMED FORCES INST PATHOL, DEPT GYNECOL & BREAST PATHOL, WASHINGTON, DC 20306 USA
关键词
endometriosis; ovary; endometrium; atypical hyperplasia;
D O I
10.1097/00004347-199601000-00001
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Endometriosis occasionally exhibits cytologic atypia in the lining of endometriotic cysts or hyperplasia resembling uterine endometrial hyperplasias, but the risk of development of adenocarcinoma in these patients is unknown. A total of 105 women with endometriosis were studied: 37 with cytologic atypia (usually in the lining of endometriotic cysts), 34 with hyperplasia resembling uterine endometrial hyperplasia, and 34 controls. For lesions resembling eutopic endometrial hyperplasia, the Kurman-Norris criteria for separating atypical hyperplasia from well-differentiated endometrial adenocarcinoma were used to subdivide this group into 23 complex atypical hyperplasias and 11 ''early carcinomas.'' Some 62 women were successfully followed for a mean of 8.7 years. One patient with early carcinoma developed a poorly differentiated endometrioid adenocarcinoma at the vaginal apex 8.1 years later, A second patient with early carcinoma developed a mullerian mucinous tumor of low malignant potential in the contralateral ovary 7 years later, Both of the latter two patients had multifocal endometriosis, Except for persistent benign endometriotic lesions in four patients, and breast carcinoma in one, all remaining patients were alive and well at last contact. It is concluded that the Kurman-Norris criteria for eutopic endometrial adenocarcinoma may be useful in identifying rare patients with endometriosis in whom there may be an increased risk of neoplastic transformation of their endometriosis.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 31 条
[1]   OVARIAN ENDOMETRIOTIC CYSTS - AN ANALYSIS OF CYTOLOGIC ATYPIA AND DNA-PLOIDY PATTERNS [J].
BALLOUK, F ;
ROSS, JS ;
WOLF, BC .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 102 (04) :415-419
[2]  
BROOKS JJ, 1977, CANCER-AM CANCER SOC, V40, P3065, DOI 10.1002/1097-0142(197712)40:6<3065::AID-CNCR2820400645>3.0.CO
[3]  
2-3
[4]  
CHALAS E, 1991, GYNECOL ONCOL, V40, P260
[5]  
CLEMENT PB, 1990, PATHOL ANNU, V25, P245
[6]  
CZERNOBI.B, 1970, CANCER-AM CANCER SOC, V26, P1142, DOI 10.1002/1097-0142(197011)26:5<1141::AID-CNCR2820260526>3.0.CO
[7]  
2-R
[8]  
CZERNOBILSKY B, 1979, OBSTET GYNECOL, V53, P318
[9]  
HYMAN MP, 1977, AM J CLIN PATHOL, V68, P522
[10]  
KURMAN RJ, 1972, CANCER-AM CANCER SOC, V29, P1653, DOI 10.1002/1097-0142(197206)29:6<1653::AID-CNCR2820290633>3.0.CO